Mizuho Cuts Corvus Pharmaceuticals (NASDAQ:CRVS) Price Target to $11.00
Corvus Pharmaceuticals (NASDAQ:CRVS – Free Report) had its price target lowered by Mizuho from $12.00 to $11.00 in a report published on Tuesday,Benzinga reports. The firm currently has an outperform rating on the stock. CRVS has been the subject of a number of other reports. HC Wainwright restated a “buy” rating and issued a $11.00 […]
Corvus Pharmaceuticals (NASDAQ:CRVS – Free Report) had its price target lowered by Mizuho from $12.00 to $11.00 in a report published on Tuesday,Benzinga reports. The firm currently has an outperform rating on the stock. CRVS has been the subject of a number of other reports. HC Wainwright restated a “buy” rating and issued a $11.00 […]
